The ability of stem cells to self-renew and develop into different cell types offers the exciting prospect of their usage in therapeutic strategies such as tissue support, cell replacement and regeneration. Thus human pluripotent stem cell research holds enormous promise to find novel therapies for a multitude of diseases such as cancer, juvenile diabetes, Alzheimer's and Parkinson's, for which there are no known cures. The free and timely flow of information between providers, researchers, and the broader life sciences community is essential to advancing the field of human pluripotent stem cell research. A registry is key to this advancement.
The mission of the International Stem Cell Registry is to provide a searchable, comprehensive database that includes published and validated unpublished information on human embryonic(hESC) and disease-specific induced pluripotent (iPS) stem cell lines. The Registry will include information on cell lines from non-profit institutions, academic centers, stem cell banks and industry based in the United States and abroad.
The International Stem Cell Registry is developed in partnership with and funded by the Massachusetts Life Sciences Center. The work of the registry is made possible by the MLSC and important collaborators, including the Harvard Stem Cell Institute.